WO2005058287A3 - Transdermal delivery system of hormones without penetration enhancers - Google Patents

Transdermal delivery system of hormones without penetration enhancers Download PDF

Info

Publication number
WO2005058287A3
WO2005058287A3 PCT/IB2004/052752 IB2004052752W WO2005058287A3 WO 2005058287 A3 WO2005058287 A3 WO 2005058287A3 IB 2004052752 W IB2004052752 W IB 2004052752W WO 2005058287 A3 WO2005058287 A3 WO 2005058287A3
Authority
WO
WIPO (PCT)
Prior art keywords
hormones
patch
penetration enhancers
transdermal delivery
gestodene
Prior art date
Application number
PCT/IB2004/052752
Other languages
English (en)
French (fr)
Other versions
WO2005058287A2 (en
Inventor
Stefan Bracht
Michael Dittgen
Petra Huber
Thomas Langguth
Dirk Schenk
Original Assignee
Stefan Bracht
Michael Dittgen
Petra Huber
Thomas Langguth
Dirk Schenk
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US52871803P priority Critical
Priority to US60/528,718 priority
Priority to EP03078881.4 priority
Priority to EP03078881 priority
Application filed by Stefan Bracht, Michael Dittgen, Petra Huber, Thomas Langguth, Dirk Schenk, Schering Ag filed Critical Stefan Bracht
Publication of WO2005058287A2 publication Critical patent/WO2005058287A2/en
Publication of WO2005058287A3 publication Critical patent/WO2005058287A3/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34702342&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2005058287(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
PCT/IB2004/052752 2003-12-12 2004-12-10 Transdermal delivery system of hormones without penetration enhancers WO2005058287A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US52871803P true 2003-12-12 2003-12-12
US60/528,718 2003-12-12
EP03078881.4 2003-12-12
EP03078881 2003-12-12

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
CN2004800413210A CN1913878B (zh) 2003-12-12 2004-12-10 无需渗透促进剂的激素透皮传递
JP2006543709A JP4965263B2 (ja) 2003-12-12 2004-12-10 浸透増強剤を必要としないホルモンの経皮送達
KR1020067013923A KR101168449B1 (ko) 2003-12-12 2004-12-10 침투 증진인자가 필요없는 호르몬의 경피 전달계
MXPA06006682A MXPA06006682A (es) 2003-12-12 2004-12-10 Hormonas de administracion transdermica que no necesitan potenciadores de penetracion.
EA200601089A EA011160B1 (ru) 2003-12-12 2004-12-10 Композиция для трансдермальной доставки гормонов без необходимости использования агентов, усиливающих проникновение, и ее применения
NZ548091A NZ548091A (en) 2003-12-12 2004-12-10 Transdermal delivery system of hormones without penetration enhancers
CA2549916A CA2549916C (en) 2003-12-12 2004-12-10 Transdermal delivery system of hormones without penetration enhancers
BRPI0417530-1A BRPI0417530B1 (pt) 2003-12-12 2004-12-10 Composição para a liberação transdérmica de hormônios sem a necessidade de melhoradores de penetração, sistema terapêutico transdérmico, e kit
AU2004298930A AU2004298930B2 (en) 2003-12-12 2004-12-10 Transdermal delivery system of hormones without penetration enhancers
IL176112A IL176112A (en) 2003-12-12 2006-06-05 Composition for transdermal delivery containing gestodene and a carrier, a transdermal therapeutic system comprising gestodene and a kit
NO20062594A NO341989B1 (no) 2003-12-12 2006-06-06 Transdermal administrasjon av hormoner uten behov for penetrasjonsenhancere.
ZA2006/05713A ZA200605713B (en) 2003-12-12 2006-07-11 Transdermal delivery system of hormones without penetration enhancers
CU20100143A CU23868B1 (es) 2003-12-12 2010-07-05 Hormonas de administración transdérmica que no necesitan potenciadores de penetración

Publications (2)

Publication Number Publication Date
WO2005058287A2 WO2005058287A2 (en) 2005-06-30
WO2005058287A3 true WO2005058287A3 (en) 2006-03-02

Family

ID=34702342

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2004/052752 WO2005058287A2 (en) 2003-12-12 2004-12-10 Transdermal delivery system of hormones without penetration enhancers

Country Status (15)

Country Link
JP (1) JP4965263B2 (und)
KR (1) KR101168449B1 (und)
CN (1) CN1913878B (und)
AU (1) AU2004298930B2 (und)
BR (1) BRPI0417530B1 (und)
CA (1) CA2549916C (und)
CU (1) CU23868B1 (und)
EA (1) EA011160B1 (und)
EC (1) ECSP066694A (und)
IL (1) IL176112A (und)
MX (1) MXPA06006682A (und)
NO (1) NO341989B1 (und)
NZ (1) NZ548091A (und)
WO (1) WO2005058287A2 (und)
ZA (1) ZA200605713B (und)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1594483T3 (da) 2003-02-21 2006-11-20 Schering Ag UV-stabilt transdermalt plaster
US8962013B2 (en) 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
DE102005050729A1 (de) * 2005-10-19 2007-04-26 Schering Ag Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption
FR2900048B1 (fr) * 2006-04-21 2012-11-16 Oreal Compositions comprenant un derive diphenyl-methane hydroxyle
AU2015203180B2 (en) * 2010-09-06 2016-06-30 Bayer Intellectual Property Gmbh Transdermal therapeutic systems with crystallization-inhibiting protective film (release liner)
LT2613772T (lt) 2010-09-06 2017-03-27 Bayer Intellectual Property Gmbh Mažos dozės transderminiai pleistrai, pasižymintys aktyviu vaisto atpalaidavimu
DE102010040299A1 (de) 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
NZ627242A (en) * 2012-01-27 2016-08-26 Agile Therapeutics Inc Transdermal hormone delivery

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992007590A1 (en) * 1990-10-29 1992-05-14 Alza Corporation Transdermal contraceptive formulations, methods and devices
EP0573133A1 (de) * 1988-10-27 1993-12-08 Schering Aktiengesellschaft Mittel zur transdermalen Applikation das Gestoden enthält
US5512292A (en) * 1990-10-29 1996-04-30 Alza Corporation Transdermal contraceptive formulations methods and devices
US5858394A (en) * 1993-08-26 1999-01-12 Schering Aktiengesellschaft Agent for transdermal administration that contains gestodene esters
US5904931A (en) * 1994-02-18 1999-05-18 Schering Aktiengesellschaft Transdermal therapeutic systems that contain sex steroids and dimethyl isosorbide
DE19906152A1 (de) * 1999-02-10 2000-08-17 Jenapharm Gmbh Wirkstoffhaltige Laminate für Transdermalsysteme
WO2002034200A2 (de) * 2000-10-27 2002-05-02 Lts Lohmann Therapie-Systeme Ag Transdermale therapeutische systeme mit lichtempfindlichen wirkstoffen
WO2002045701A2 (en) * 2000-12-05 2002-06-13 Noven Pharmaceuticals, Inc. Crystallization inhibition of drugs in transdermal drug delivery systems

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5820878A (en) * 1994-11-18 1998-10-13 Hisamitsu Pharmaceutical Co., Inc. Percutaneously absorbable patch
JP4346696B2 (ja) * 1996-05-28 2009-10-21 久光製薬株式会社 経皮治療用装置
JP4167750B2 (ja) * 1997-04-16 2008-10-22 久光製薬株式会社 経皮吸収用基剤及び該基剤を含有する経皮吸収製剤
JP4399044B2 (ja) * 1998-10-14 2010-01-13 久光製薬株式会社 吸収促進剤及び該吸収促進剤を有してなる経皮吸収製剤
EP1197212A4 (en) * 1999-07-01 2004-06-02 Hisamitsu Pharmaceutical Co Adhesive preparation for percutaneous absorption

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0573133A1 (de) * 1988-10-27 1993-12-08 Schering Aktiengesellschaft Mittel zur transdermalen Applikation das Gestoden enthält
WO1992007590A1 (en) * 1990-10-29 1992-05-14 Alza Corporation Transdermal contraceptive formulations, methods and devices
US5512292A (en) * 1990-10-29 1996-04-30 Alza Corporation Transdermal contraceptive formulations methods and devices
US5858394A (en) * 1993-08-26 1999-01-12 Schering Aktiengesellschaft Agent for transdermal administration that contains gestodene esters
US5904931A (en) * 1994-02-18 1999-05-18 Schering Aktiengesellschaft Transdermal therapeutic systems that contain sex steroids and dimethyl isosorbide
DE19906152A1 (de) * 1999-02-10 2000-08-17 Jenapharm Gmbh Wirkstoffhaltige Laminate für Transdermalsysteme
WO2002034200A2 (de) * 2000-10-27 2002-05-02 Lts Lohmann Therapie-Systeme Ag Transdermale therapeutische systeme mit lichtempfindlichen wirkstoffen
WO2002045701A2 (en) * 2000-12-05 2002-06-13 Noven Pharmaceuticals, Inc. Crystallization inhibition of drugs in transdermal drug delivery systems

Also Published As

Publication number Publication date
BRPI0417530A (pt) 2007-03-13
CU20100143A7 (es) 2011-10-31
NO20062594L (no) 2006-07-10
NO341989B1 (no) 2018-03-12
KR101168449B1 (ko) 2012-07-25
KR20060128910A (ko) 2006-12-14
ECSP066694A (es) 2006-10-31
AU2004298930B2 (en) 2009-11-26
CA2549916A1 (en) 2005-06-30
IL176112A (en) 2011-02-28
CU23868B1 (es) 2013-03-27
AU2004298930A1 (en) 2005-06-30
CN1913878A (zh) 2007-02-14
JP2007513938A (ja) 2007-05-31
EA200601089A1 (ru) 2006-12-29
CA2549916C (en) 2013-09-17
IL176112D0 (en) 2006-10-05
NZ548091A (en) 2009-12-24
CN1913878B (zh) 2010-05-26
BRPI0417530B1 (pt) 2018-01-23
WO2005058287A2 (en) 2005-06-30
MXPA06006682A (es) 2006-08-11
EA011160B1 (ru) 2009-02-27
ZA200605713B (en) 2008-01-08
JP4965263B2 (ja) 2012-07-04

Similar Documents

Publication Publication Date Title
EP0409910B1 (en) Laminated composite for transdermal administration of fentanyl
CA1316106C (en) Skin permeation enhancer compositions using glycerol monolaurate
AU710760B2 (en) Drug delivery compositions for improved stability of steroids
EP0744944B1 (de) Transdermale therapeutische systeme enthaltend sexualsteroide
EP1323430B1 (en) Composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
EP2773333B1 (en) Dermal delivery compositions and methods
EP0716615B2 (en) Low flux transdermal potent drug delivery system
US5314694A (en) Transdermal formulations, methods and devices
AU594908B2 (en) Transdermal contraceptive formulations
JP6109280B2 (ja) 活性物質の利用率及び用量精度の高い経皮治療システム
RU2219926C2 (ru) Чрескожная терапевтическая система (чтс), содержащая антиоксидант
JP2650710B2 (ja) スクロースエステルを用いる皮膚透過促進剤組成物
AU782249B2 (en) Patches containing buprenorphine hydrochloride
DE60018797T2 (de) Hydroxide freisetzende verbindungen zum verbessern der hautdurchlässigkeit
US5750137A (en) Monoglyceride/lactate ester permeation enhancer
CY1116520T1 (el) Φαρμακοτεχνικη μορφη fulvestrant
DE69721377T2 (de) Arzneimittel zur transdermalen Verabreichung von einem Östrogen oder Progestin oder einer Mischung davon
US5198223A (en) Transdermal formulations, methods and devices
AU727811B2 (en) Composition for the transdermal administration of steroid drugs
DE4344405C2 (de) Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption
CA2064765C (en) Biphasic transdermal drug delivery device
US5122382A (en) Transdermal contraceptive formulations, methods and devices
US20030161870A1 (en) Dual enhancer composition for topical and transdermal drug delivery
US20150265547A1 (en) Dermal delivery device
US4568343A (en) Skin permeation enhancer compositions

Legal Events

Date Code Title Description
AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 176112

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 3279/DELNP/2006

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2549916

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2006543709

Country of ref document: JP

Ref document number: 12006501154

Country of ref document: PH

WWE Wipo information: entry into national phase

Ref document number: PA/a/2006/006682

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2004298930

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: CR2006-008465

Country of ref document: CR

WWE Wipo information: entry into national phase

Ref document number: 548091

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 06064000

Country of ref document: CO

WWE Wipo information: entry into national phase

Ref document number: 200601089

Country of ref document: EA

ENP Entry into the national phase in:

Ref document number: 2004298930

Country of ref document: AU

Date of ref document: 20041210

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004298930

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2006/05713

Country of ref document: ZA

Ref document number: 1020067013923

Country of ref document: KR

Ref document number: 200605713

Country of ref document: ZA

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 200480041321.0

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 1020067013923

Country of ref document: KR

122 Ep: pct application non-entry in european phase
ENP Entry into the national phase in:

Ref document number: PI0417530

Country of ref document: BR

WWE Wipo information: entry into national phase

Ref document number: D2010143

Country of ref document: CU